IMC Chicago’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.18M Buy
+173,689
New +$4.54M ﹤0.01% 2290
2025
Q3
Sell
-106,092
Closed -$2.62M 3812
2025
Q2
$2.57M Buy
+106,092
New +$2.47M ﹤0.01% 1830
2024
Q2
Sell
-61,248
Closed -$1.69M 2746
2024
Q1
$1.7M Buy
+61,248
New +$1.7M ﹤0.01% 1459
2023
Q3
Sell
-12,013
Closed -$425K 1629
2023
Q2
$441K Buy
+12,013
New +$468K ﹤0.01% 1202
2022
Q2
Sell
-70,164
Closed -$3.58M 1123
2022
Q1
$3.63M Buy
70,164
+53,631
+324% +$2.78M ﹤0.01% 621
2021
Q4
$976K Buy
+16,533
New +$819K ﹤0.01% 984
2020
Q4
Sell
-17,371
Closed -$605K 1090
2020
Q3
$605K Buy
+17,371
New +$609K ﹤0.01% 821
2019
Q4
Sell
-12,834
Closed -$457K 841
2019
Q3
$437K Buy
+12,834
New +$467K ﹤0.01% 660

Other funds holding PFE

IMC Chicago's PFE Position: Q2 2026 in Review

IMC Chicago opened a new position in Pfizer (PFE) in Q2 2026: 173,689 shares worth $4.18M. The stake represents ﹤0.01% of the portfolio and ranks #2290 among its holdings. This is a return to the name: IMC Chicago previously reported a position in PFE as recently as Q2 2025.

IMC Chicago first reported a position in PFE in Q3 2019 and has held it in 8 quarters since. 1,997 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • IMC Chicago held 173,689 shares of Pfizer worth $4.18M as of Q2 2026.
  • Pfizer was a new IMC Chicago position in Q2 2026.
  • Pfizer made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2290 holding.
  • IMC Chicago first reported a position in Pfizer in Q3 2019 and has held it in 8 quarters since.
  • 1,997 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.